Multiple Roles of the Extracellular Matrix in Inflammation

被引:79
作者
Korpos, E. [1 ]
Wu, C. [1 ]
Sorokin, L. [1 ]
机构
[1] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany
关键词
Basement membrane; laminin; inflammation; extravasation; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NONOBESE DIABETIC MICE; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; ARG-GLY-ASP; ADULT-MOUSE TISSUES; CD8+ T-CELLS; BASEMENT-MEMBRANE; NOD MICE; LEUKOCYTE MIGRATION;
D O I
10.2174/138161209787846685
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Extracellular matrix (ECM) provides a physical scaffold for cells but also provides specific molecular and spatial information that influences cell proliferation, differentiation and apoptosis. This review addresses the multiple roles of ECM in inflammatory responses, in particular in leukocyte extravasation at sites of inflammation, and the potential of exploiting such cell-ECM interactions to interfere with defined steps in the inflammatory process. In the course of an inflammation leukocytes not only have to penetrate the vascular endothelial cell monolayer, but also the underlying endothelial cell basement membrane and invade the interstitial matrix of the stroma to reach the site of inflammation. The endothelial cell basement membrane may directly influence leukocyte recruitment to the inflammed tissue by providing differential signals resulting from its spatial and molecular composition, or indirectly by its potential to bind and present cytokines or chemotactic factors. Proteases (in particular matrix metalloproteinases (MMP)) released at sites of inflammation selectively process ECM and cell surface molecules, which may result in the release of bioactive fragments that may function as chemoattractants for different leukocytes subsets or modulate the activity/function of resident mesenchymal and immune cells. In addition, MMPs have been shown to process chemokines modulating their chemoattractant properties. To be able to mimic or inhibit some of the ECM functions or proteolytic events that occur during inflammation, through the use of specific protein fragments, would provide a means by which the inflammatory process could be manipulated, an area however that remains largely unexplored.
引用
收藏
页码:1349 / 1357
页数:9
相关论文
共 94 条
[1]
ACHSTATTER T, 1985, J HISTOCHEM CYTOCHEM, V33, P415
[2]
A site on laminin α5, AQARSAASKVKVSMKF, induces inflammatory cell production of matrix metalloproteinase-9 and chemotaxis [J].
Adair-Kirk, TL ;
Atkinson, JJ ;
Broekelmann, TJ ;
Doi, M ;
Tryggvason, K ;
Miner, JH ;
Mecham, RP ;
Senior, RM .
JOURNAL OF IMMUNOLOGY, 2003, 171 (01) :398-406
[3]
Adamson P, 1999, J IMMUNOL, V162, P2964
[4]
Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis [J].
Agrawal, S ;
Anderson, P ;
Durbeej, M ;
van Rooijen, N ;
Ivars, F ;
Opdenakker, G ;
Sorokin, LM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (04) :1007-1019
[5]
From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts [J].
Alon, R ;
Feigelson, S .
SEMINARS IN IMMUNOLOGY, 2002, 14 (02) :93-104
[6]
The NOD mouse: A model of immune dysregulation [J].
Anderson, MS ;
Bluestone, JA .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :447-485
[7]
NOD mice and autoimmunity [J].
Aoki, CA ;
Borchers, AT ;
Ridgway, WM ;
Keen, CL ;
Ansari, AA ;
Gershwin, ME .
AUTOIMMUNITY REVIEWS, 2005, 4 (06) :373-379
[8]
IDENTIFICATION OF THE ARG-GLY-ASP SEQUENCE IN LAMININ-A CHAIN AS A LATENT CELL-BINDING SITE BEING EXPOSED IN FRAGMENT P1 [J].
AUMAILLEY, M ;
GERL, M ;
SONNENBERG, A ;
DEUTZMANN, R ;
TIMPL, R .
FEBS LETTERS, 1990, 262 (01) :82-86
[9]
Autoimmune diabetes: how many steps for one disease? [J].
Bach, JF ;
Chatenoud, L ;
Herbelin, A ;
Gombert, JM ;
Carnaud, C .
RESEARCH IN IMMUNOLOGY, 1997, 148 (05) :332-338
[10]
THE PATHOGENESIS OF ADOPTIVE MURINE AUTOIMMUNE DIABETES REQUIRES AN INTERACTION BETWEEN ALPHA-4-INTEGRINS AND VASCULAR CELL-ADHESION MOLECULE-1 [J].
BARON, JL ;
REICH, EP ;
VISINTIN, I ;
JANEWAY, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1700-1708